लोड हो रहा है...

In vivo administration of BL-3050: highly stable engineered PON1-HDL complexes

BACKGROUND: Serum paraoxonase (PON1) is a high density lipoprotein (HDL)-associated enzyme involved in organophosphate (OP) degradation and prevention of atherosclerosis. PON1 comprises a potential candidate for in vivo therapeutics, as an anti-atherogenic agent, and for detoxification of pesticides...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Gaidukov, Leonid, Bar, Dganit, Yacobson, Shiri, Naftali, Esmira, Kaufman, Olga, Tabakman, Rinat, Tawfik, Dan S, Levy-Nissenbaum, Etgar
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2009
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC2785756/
https://ncbi.nlm.nih.gov/pubmed/19922610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6904-9-18
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!